Urgent.News

600+ sources. One page. See who else covered it.

Editions

World

How iX Biopharma turned conviction into opportunity

After losing a key licensing partner, the Singapore pharmaceutical company continued advancing its lead drug programme. That persistence opened new pathways to commercialisation – and unlocked value beyond the laboratory.

How iX Biopharma turned conviction into opportunity

We haven't written up this one. Channel News Asia has the full story — the link below goes straight to it.

Read the original at channelnewsasia.com →

More in World

Silver Lake eyes US$51bil Workday buyout

Silver Lake eyes US$51bil Workday buyout

CALIFORNIA: Private equity firm Silver Lake is in talks to acquire Workday in a deal that would rank among the largest software buyouts in history, according to people familiar with the matter.

More from Friday 14 August →